NewsRx

Search our medical news database

Proteomics

Calibrant Biosystems Announces Appointment of Dr. Satya Saxena as Vice-President of Research

Published in Blood Weekly, May 1st, 2008

Calibrant Biosystems announced the appointment of Dr. Satya Saxena as its Vice-President of Research. Dr. Saxena will lead Calibrant's proteomic technology and product development programs. His primary focus will include expanding and validating the Gemini(TM) platform technology beyond the initial programs in oncology. He will also oversee the continuing drug development efforts involving lead compounds in ovarian, brain, and breast cancer.

Dr. Saxena joins Calibrant from the National Institute on Aging, National Institutes of Health (NIH), where he served as Chief of the Proteomics and Mass Spectrometry Facility. While there, he steered the development of innovative...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook